Innova Captab Limited

₹1,067As of Sun 8 Nov 2026, 12:00 UTC
NSE:INNOVACAPHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR 26.96%
Div yield 0.28%
ROE 13.75%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.13
PE TTM 39.65
TSR TTM 28.80%
Mkt cap ₹61.08B
ROIC 11.42%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,325
24.17%
(54.99%)
Hold 11|1|5|3|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
24.24
24.14
26.09
27.90
32.91%
18.29%
15.91%
13.94%
Revenue₹B
6.888
6.758
7.005
7.308
7.81%
3.47%
7.15%
7.82%
Peers (US$623.6M)
Cap (US$)
PE
676.6M
20.29x
669.6M
3.849x
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
1.371
0.207
0.179
EBIT/Intx
0.372
0.283
0.278
Own earn%
(6.10)
46.99
55.15
Sh yield%
55.32
59.25
58.79
Owners
Insiders/Inst%
11.44
52.06
Short interest%
2.24
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
21–29
$1 testx
—
Incr. ROIC%
0